Personalized Neoantigen Vaccine Plus IL-12 (INO-9012) Versus Active Surveillance in Subjects With High-Risk HCC
Clinical trial NCT07722741 · RECRUITING
Trial details
- NCT number
- NCT07722741
- Sponsor
- Geneos Therapeutics
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2029-09-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.